ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO409

Assessing the Role of Cooling on Hemodynamics of Patients on Dialysis in Inpatient Settings

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Xue, Hui, Kaiser Permanente Southern California, San Diego, California, United States
  • Liu, In-Lu Amy, Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, United States
  • Chen, Aiyu, Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, United States
  • Lin, Edward, Southern California Permanente Medical Group, Pasadena, California, United States
  • Creekmur, Beth, Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena, California, United States
  • Abcar, Antoine C., Kaiser Permanente Southern California, Los Angeles, California, United States
  • Chiu, Josephine J., Southern California Permanente Medical Group, Pasadena, California, United States
  • Cho, Paula S., Southern California Permanente Medical Group, Pasadena, California, United States
  • Fong, Patrick, Southern California Permanente Medical Group, Pasadena, California, United States
  • Sim, John J., Kaiser Permanente Southern California, Los Angeles, California, United States
  • Suh, Annie, Southern California Permanente Medical Group, Pasadena, California, United States
  • Ali, Behzad, Southern California Permanente Medical Group, Pasadena, California, United States
Background

The effect of cooling dialysate to reduce intradialytic hypotension (IDH) in the inpatient setting is unknown.

Methods

Retrospective Cohort: Session Level: 2019 inpatient (IP) HD sessions (n=17357) were evaluated at Kaiser Permanente Southern California (KPSC). Using multivariable repeated measure models; covariates included age, gender, race, IP utilization, IP duration, HD sessions, HD temp, blood pressure (Bp), fluid removed, BMI, and Elixhauser index (EI). Patient Level: 3243 patients received IP HD. Multivariable analysis (Fine and Gray, Cox proportional hazards, Robust Poisson, multiple regression) examined 30-day and 12-month outcomes: re-admissions (re-IP), total IP/day, 30-day-alive-at-home, hospice referral and death. Covariates included age, sex, race, index IP characteristics, prior utilization and comorbidity.
Prospective cross-over design cohort: Session: Examined Cooled dialysate <36.5°C (CD) on IDH in 6 KPSC hospitals over 6-months in 2022. Each hospital served as its own control and was assigned to either 37.0°C or 35.5°C for the first 3 months, then switched in the 2nd 3 months. 6698 IP HD sessions were evaluated using a nested multivariable repeated measure model. Covariates included assigned temp (AT) and retrospective variables listed above. Patient: 1159 patients were followed for 12-months using models, covariates and outcomes similar to retrospective patient analyses with the addition of AT.

Results

Retrospective Cohort: Session: IDH risk factors were CD, older age, prior IP, lower ultrafiltration, under-weight, service area and higher EI. Higher Bp significantly reduce risk. Patient: IDH significantly increased risk of death, total IP/day and increased re-IP in 30-day.
Prospective cross-over design cohort: Session: Lower AT (35.5 °C) and higher Bp could significantly reduce IDH risk. Patient: Lower AT tended to reduce outcomes for patients with less comorbidities (EI < 11) in 30-day. Due to small sample size, no risk reductions were significant.
Comparison: Session: Prospective cross-over design reduced the effect of unmeasured confounders and shows AT (35.5 °C) could significantly reduce IDH risk (0.83 (0.71-0.97)).

Conclusion

CD reduced the risks of IP IDH, healthier patients had the greatest short-term benefits. Larger sample size needed for future work.